Evidence map›Paper›PMID 39661238›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2025

Optimizing genetic testing strategy for suspected attenuated adenomatous polyposis: effective solutions in public health systems.

Natalia García-Simón, Fátima Valentín, Ana Royuela, Beatriz Hidalgo-Calero, Ricardo Blázquez-Martín, Montserrat de-Miguel-Reyes, José María Sánchez-Zapardiel, Luisa Adán-Merino, Alejandro Rodríguez-Festa, Patricia Gallego-Gil and 7 more

Abstract read
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Pathogenicity Prediction of Missense Variations in Hereditary Cancer Genes.International journal of molecular sciences · 2026
    Article
  2. Article
  3. Genetic predisposition to polyposis syndromes.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Natalia García-SimónHereditary Cancer Unit, Medical Oncology Department, Puerta de Hierro University Hospital, Majadahonda, 28222, Madrid, Spain.ORCID http://orcid.org/0000-0003-0893-3297
Fátima ValentínGastroenterology Department, Biomedical Research Institute (IDIPHISA), Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
Ana RoyuelaBiostatistics Unit, Puerta de Hierro Biomedical Research Institute (IDIPHISA), CIBERESP, ISCIII. Majadahonda, Madrid, Spain.
Beatriz Hidalgo-CaleroHereditary Cancer Laboratory, 12 de Octubre University Hospital, Madrid, Spain.
Ricardo Blázquez-MartínHereditary Cancer Laboratory, 12 de Octubre University Hospital, Madrid, Spain.
Montserrat de-Miguel-ReyesHereditary Cancer Laboratory, 12 de Octubre University Hospital, Madrid, Spain.
José María Sánchez-ZapardielHereditary Cancer Laboratory, 12 de Octubre University Hospital, Madrid, Spain.
Luisa Adán-MerinoGastroenterology Department, Infanta Leonor University Hospital, Madrid, Spain.
Alejandro Rodríguez-FestaHereditary Cancer Unit, Medical Oncology Department, Puerta de Hierro University Hospital, Majadahonda, 28222, Madrid, Spain.
Patricia Gallego-GilHereditary Cancer Unit, Medical Oncology Department, Puerta de Hierro University Hospital, Majadahonda, 28222, Madrid, Spain.
Pilar Mediavilla-MedelHereditary Cancer Unit, Medical Oncology Department, Puerta de Hierro University Hospital, Majadahonda, 28222, Madrid, Spain.
Laura Quiñonero-MorenoHereditary Cancer Unit, Medical Oncology Department, Puerta de Hierro University Hospital, Majadahonda, 28222, Madrid, Spain.
Lourdes GutiérrezHereditary Cancer Unit, Medical Oncology Department, Puerta de Hierro University Hospital, Majadahonda, 28222, Madrid, Spain.
Alberto Herreros-de-TejadaGastroenterology Department, Biomedical Research Institute (IDIPHISA), Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
Antonio SánchezHereditary Cancer Unit, Medical Oncology Department, Puerta de Hierro University Hospital, Majadahonda, 28222, Madrid, Spain.
Mariano ProvencioHereditary Cancer Unit, Medical Oncology Department, Puerta de Hierro University Hospital, Majadahonda, 28222, Madrid, Spain.
Atocha RomeroHereditary Cancer Unit, Medical Oncology Department, Puerta de Hierro University Hospital, Majadahonda, 28222, Madrid, Spain. atocha10@hotmail.com.ORCID http://orcid.org/0000-0002-1634-7397

Funding

Instituto de Salud Carlos III CM22/00213Instituto de Salud Carlos III FI22/00321
6 · The paper itself

Abstract

backgroundAPC and MUTYH genes are key in hereditary attenuated adenomatous polyposis syndromes. Guidelines recommend genetic testing based on polyp count, often overlooking age despite its impact on polyp prevalence.

aimTo enhance genetic testing strategies for suspected attenuated adenomatous polyposis by combining polyp count and age in a probability calculator.

methodsRetrospective study of adult patients referred to NGS genetic testing for suspected attenuated adenomatous polyposis (accumulated history of < 100 adenomas) (discovery cohort, N = 138). Data included age, adenoma count, and test results. A multivariable logistic regression model was developed to associate positive genetic test results with age and adenoma count. The model was externally validated with 259 patients from two tertiary hospitals in our region (validation cohort, N = 259).

resultsIn the discovery cohort, 13 (9.4%) patients had pathogenic mutations, being younger (OR:0.91, 95%CI 0.86-0.96) and having more adenomas (OR:1.08, 95%CI 1.04-1.13) compared to negative cases. The logistic regression model combining age and polyp count demonstrated an AUC of 0.92. Using a cutoff probability of 3.5%, the model achieved 100% sensitivity and 58% specificity in identifying positive cases. In the external validation, the model accurately predicted 14 out of 16 positive cases (88%). The remaining two positive cases were a patient with an AXIN2 mutation in heterozygosis, and a patient with a NTHL1 mutation in homozygosis. Performance evaluation of both hospitals yielded AUC values of 0.77 and 0.90.

conclusionsOlder individuals with fewer polyps are less likely have hereditary syndromes. Including age in genetic testing criteria can enhance patient selection and cost-effectiveness.

Indexed as

Adenomatous Polyposis ColiGenetic TestingPublic HealthAdenomaAdultAgedAge FactorsDNA GlycosylasesFemaleHumansMaleMiddle AgedMutationRetrospective StudiesYoung AdultDNA GlycosylasesmutY adenine glycosylaseAdenomasAgeAPCGenetic testingHereditary attenuated adenomatous polyposisMUTYH

Identifiers

PMID39661238
PMCPMC12084234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.